Sphera Funds Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.31M | Sell |
1,959,610
-347,509
| -15% | -$942K | 1.25% | 24 |
|
2025
Q1 | $7.82M | Sell |
2,307,119
-244,500
| -10% | -$829K | 1.8% | 13 |
|
2024
Q4 | $10.5M | Buy |
2,551,619
+1,254,298
| +97% | +$5.17M | 1.9% | 11 |
|
2024
Q3 | $3.23M | Buy |
1,297,321
+300
| +0% | +$747 | 0.51% | 56 |
|
2024
Q2 | $3.42M | Buy |
+1,297,021
| New | +$3.42M | 0.47% | 57 |
|
2015
Q2 | – | Sell |
-903
| Closed | -$1.65M | – | 134 |
|
2015
Q1 | $1.65M | Sell |
903
-47
| -5% | -$86.1K | 0.17% | 109 |
|
2014
Q4 | $2.27M | Sell |
950
-470
| -33% | -$1.12M | 0.39% | 79 |
|
2014
Q3 | $3.48M | Buy |
+1,420
| New | +$3.48M | 0.43% | 45 |
|